Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
89.9M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
230K
-
Shares change
-
-60.8K
-
Total reported value, excl. options
-
$8.19M
-
Value change
-
-$2.16M
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$35.58
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q4 2023
3 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q4 2023.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 230K shares
of 89.9M outstanding shares and own 0.26% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.44M shares), FEDERATED HERMES, INC. (3.88M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.57M shares), JANUS HENDERSON GROUP PLC (3.55M shares), VANGUARD GROUP INC (3.48M shares), STATE STREET CORP (2.99M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.93M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.63M shares), Boxer Capital, LLC (2.2M shares), and Capital Research Global Investors (1.98M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.